PRINSTON INC FDA Approval ANDA 206653

ANDA 206653

PRINSTON INC

FDA Drug Application

Application #206653

Application Sponsors

ANDA 206653PRINSTON INC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE, DELAYED REL PELLETS;ORALEQ 20MG BASE0DULOXETINE HYDROCHLORIDEDULOXETINE HYDROCHLORIDE
002CAPSULE, DELAYED REL PELLETS;ORALEQ 30MG BASE0DULOXETINE HYDROCHLORIDEDULOXETINE HYDROCHLORIDE
003CAPSULE, DELAYED REL PELLETS;ORALEQ 60MG BASE0DULOXETINE HYDROCHLORIDEDULOXETINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-05-18STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206653
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DULOXETINE HYDROCHLORIDE","activeIngredients":"DULOXETINE HYDROCHLORIDE","strength":"EQ 20MG BASE","dosageForm":"CAPSULE, DELAYED REL PELLETS;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DULOXETINE HYDROCHLORIDE","activeIngredients":"DULOXETINE HYDROCHLORIDE","strength":"EQ 30MG BASE","dosageForm":"CAPSULE, DELAYED REL PELLETS;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DULOXETINE HYDROCHLORIDE","activeIngredients":"DULOXETINE HYDROCHLORIDE","strength":"EQ 60MG BASE","dosageForm":"CAPSULE, DELAYED REL PELLETS;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/18\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.